Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VLA1553 Chikungunya Vaccine in Adolescents
NCT04650399Phase 3Completed
- Sponsor
- Instituto Butantan
- Start
- Feb 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of chikungunya vaccine (live) in Chikungunya (CHIKV), sponsored by Instituto Butantan. Started Feb 2022; status: completed.
02
Drugs
chikungunya vaccine (live)
03
Conditions
Chikungunya (CHIKV)
Beyond the preview
Go deeper on NCT04650399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04650399.